: The FDA authorized the third antibody infusion therapy. Here’s why Vir and GSK say the U.S. still needs COVID-19 treatments


There are now three antibody-based treatments available in the U.S. to treat adults and teens with mild or moderate forms of COVID-19, though all require intravenous infusions and are not the kind of medications that can be picked up at a local pharmacy.

Top Ten: Weekend reads: AMC and GameStop rocket again

Previous article

: American Eagle sales could quadruple as shoppers shift from sweats to mom jeans

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News